{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T05:30:12Z","timestamp":1780464612137,"version":"3.54.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Nearly half of the women reaching menopause in the United States (US) experience changes to reproductive health and quality of life. Vaginal estrogen is a widely recognized treatment option for menopausal symptoms. Our study aims to investigate public interest through Google search trends and its comparative prevalence in medical literature for postmenopausal women. A retrospective analysis of Google search trends data for the term \u201cvaginal estrogen\u201d and other related words was conducted, and a time series analysis with a 6-month simple moving average and statistical modeling were employed to evaluate the trends and relationships between these variables. Research volume and relevance were measured through PubMed and Google Scholar, respectively, for post-menopausal symptom management. Our results reveal an increasing search interest in \u201cvaginal estrogen\u201d and the number of articles on this treatment option among post-menopausal women. While this study does not point to causation, it suggests a correlation in growing interest in vaginal estrogen from the public and amongst medical researchers. The data underscore that the medical community\u2019s endorsement of vaginal estrogen may be fostering greater awareness and acceptance of this therapy for post-menopausal women, or vice versa. Further research is needed to determine its cost-effectiveness and equal accessibility to all patients.<\/jats:p>","DOI":"10.1038\/s41443-025-01192-6","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T09:09:54Z","timestamp":1761642594000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Analyzing google search trends for \u201cvaginal estrogen\u201d and its relationship to medical recommendations for post-menopausal women"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3367-7070","authenticated-orcid":false,"given":"Yash H.","family":"Kadakia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana S.","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed A. M.","family":"Hammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elia","family":"Abou Chawareb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake A.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7847-0246","authenticated-orcid":false,"given":"Faysal A.","family":"Yafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia H.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica M.","family":"Yih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"1192_CR1","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.mcna.2015.01.006","volume":"99","author":"TA Takahashi","year":"2015","unstructured":"Takahashi TA, Johnson KM. Menopause. Medical Clinics of North America. 2015;99:521\u201334.","journal-title":"Medical Clinics of North America"},{"key":"1192_CR2","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1097\/GME.0000000000000329","volume":"21","author":"DJ Portman","year":"2014","unstructured":"Portman DJ, Gass ML. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the international society for the study of women\u2019s sexual health and the North American menopause society. Menopause. 2014;21:1063\u20138.","journal-title":"Menopause"},{"key":"1192_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/frph.2021.779398","volume":"3","author":"ACA Sarmento","year":"2021","unstructured":"Sarmento ACA, Costa APF, Vieira-Baptista P, Giraldo PC, Eleut\u00e9rio J Jr., Gon\u00e7alves AK. Genitourinary syndrome of menopause: epidemiology, physiopathology, clinical manifestation and diagnostic. Frontier in Reproductive Health. 2021;3:779398.","journal-title":"Frontier in Reproductive Health"},{"key":"1192_CR4","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1097\/GME.0000000000001609","volume":"27","author":"The NAMS 2020 GSM Position Statement Editorial Panel","year":"2020","unstructured":"The NAMS 2020 GSM Position Statement Editorial Panel. The 2020 genitourinary syndrome of menopause position statement of The North American menopause society. Menopause. 2020;27:976\u201392.","journal-title":"Menopause"},{"key":"1192_CR5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3109\/13697137.2015.1129166","volume":"19","author":"RJ Baber","year":"2016","unstructured":"Baber RJ, Panay N, Fenton A. International menopause society recommendations on women\u2019s midlife health and menopause hormone therapy. Climacteric. 2016;19:109\u201350.","journal-title":"Climacteric"},{"key":"1192_CR6","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1089\/jwh.2008.1281","volume":"18","author":"C Lynch","year":"2009","unstructured":"Lynch C. Vaginal estrogen therapy for the treatment of atrophic vaginitis. Journal of Women\u2019s Health (Larchmt). 2009;18:1595\u2013606.","journal-title":"Journal of Women\u2019s Health (Larchmt)"},{"key":"1192_CR7","unstructured":"Google. Google Trends 2024 [cited 2024]. Available from: https:\/\/www.google.com\/trends."},{"key":"1192_CR8","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/ICO.0000000000002579","volume":"40","author":"DB Azzam","year":"2021","unstructured":"Azzam DB, Nag N, Tran J, Chen L, Visnagra K, Marshall K, et al. A novel epidemiological approach to geographically mapping population dry eye disease in the United States through google trends. Cornea. 2021;40:282\u201391.","journal-title":"Cornea"},{"key":"1192_CR9","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/GME.0000000000001284","volume":"26","author":"SN Bhupathiraju","year":"2018","unstructured":"Bhupathiraju SN, Grodstein F, Stampfer MJ, Willett WC, Crandall CJ, Shifren JL, et al. Vaginal estrogen use and chronic disease risk in the nurses\u2019 health study. Menopause. 2018;26:603\u201310.","journal-title":"Menopause"},{"key":"1192_CR10","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1097\/GME.0000000000000996","volume":"24","author":"JV Pinkerton","year":"2017","unstructured":"Pinkerton JV, Kaunitz AM, Manson JE. Vaginal estrogen in the treatment of genitourinary syndrome of menopause and risk of endometrial cancer: an assessment of recent studies provides reassurance. Menopause. 2017;24:1329\u201332.","journal-title":"Menopause"},{"key":"1192_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/GME.0000000000000956","volume":"25","author":"CJ Crandall","year":"2018","unstructured":"Crandall CJ, Hovey KM, Andrews CA, Chlebowski RT, Stefanick ML, Lane DS, et al. Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the women\u2019s health initiative observational study. Menopause. 2018;25:11\u201320.","journal-title":"Menopause"},{"key":"1192_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/GME.0000000000001416","volume":"27","author":"MFR Paraiso","year":"2020","unstructured":"Paraiso MFR, Ferrando CA, Sokol ER, Rardin CR, Matthews CA, Karram MM, et al. A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: the vaginal laser therapy versus vaginal estrogen therapy (VeLVET) trial. Menopause. 2020;27:50\u20136.","journal-title":"Menopause"},{"key":"1192_CR13","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/GME.0000000000001221","volume":"26","author":"C Biehl","year":"2019","unstructured":"Biehl C, Plotsker O, Mirkin S. A systematic review of the efficacy and safety of vaginal estrogen products for the treatment of genitourinary syndrome of menopause. Menopause. 2019;26:431\u201353.","journal-title":"Menopause"},{"key":"1192_CR14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/SPV.0000000000000749","volume":"27","author":"KL Ferrante","year":"2021","unstructured":"Ferrante KL, Wasenda EJ, Jung CE, Adams-Piper ER, Lukacz ES. Vaginal estrogen for the prevention of recurrent urinary tract infection in postmenopausal women: a randomized clinical trial. Female Pelvic Medicine and Reconstructive Surgery. 2021;27:112\u20137.","journal-title":"Female Pelvic Medicine and Reconstructive Surgery"},{"key":"1192_CR15","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1097\/GME.0000000000000840","volume":"24","author":"CM Ripperda","year":"2017","unstructured":"Ripperda CM, Maldonado PA, Acevedo JF, Keller PW, Akgul Y, Shelton JM, et al. Vaginal estrogen: a dual-edged sword in postoperative healing of the vaginal wall. Menopause. 2017;24:838\u201349.","journal-title":"Menopause"},{"key":"1192_CR16","doi-asserted-by":"publisher","first-page":"727.e1","DOI":"10.1016\/j.ajog.2020.08.006","volume":"223","author":"K Thomas-White","year":"2020","unstructured":"Thomas-White K, Taege S, Limeira R, Brincat C, Joyce C, Hilt EE, et al. Vaginal estrogen therapy is associated with increased Lactobacillus in the urine of postmenopausal women with overactive bladder symptoms. American Journal of Obstetrics and Gynecology. 2020;223:727.e1\u2013727.e11.","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"1192_CR17","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1097\/SPV.0000000000000790","volume":"27","author":"MR Meister","year":"2021","unstructured":"Meister MR, Wang C, Lowder JL, Mysorekar IU. Vaginal estrogen therapy is associated with decreased inflammatory response in postmenopausal women with recurrent urinary tract infections. Female Pelvic Medicine and Reconstructive Surgery. 2021;27:e39\u2013e44.","journal-title":"Female Pelvic Medicine and Reconstructive Surgery"},{"key":"1192_CR18","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1097\/GME.0000000000001797","volume":"28","author":"P Dutra","year":"2021","unstructured":"Dutra P, Heinke T, Pinho SC, Focchi GRA, Tso FK, de Almeida BC, et al. Comparison of topical fractional CO2 laser and vaginal estrogen for the treatment of genitourinary syndrome in postmenopausal women: a randomized controlled trial. Menopause. 2021;28:756\u201363.","journal-title":"Menopause"},{"key":"1192_CR19","first-page":"e2232563","volume":"5","author":"Y-C Jang","year":"2022","unstructured":"Jang Y-C, Leung CY, Huang H-L. Comparison of severity of genitourinary syndrome of menopause symptoms after carbon dioxide laser vs vaginal estrogen therapy: a systematic review and meta-analysis. Journal of the American Medical Association Network Open. 2022;5:e2232563.","journal-title":"Journal of the American Medical Association Network Open"},{"key":"1192_CR20","unstructured":"2023 Year in Review. Maine Office of the State Economist. 2024. https:\/\/www.maine.gov\/dafs\/economist\/sites\/maine.gov.dafs.economist\/files\/releases\/2023%20Year%20in%20Review.pdf."},{"key":"1192_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.935608","volume":"10","author":"J Yu","year":"2022","unstructured":"Yu J, Meng S. Impacts of the internet on health inequality and healthcare access: a cross-country study. Frontiers in Public Health. 2022;10:935608.","journal-title":"Frontiers in Public Health"},{"key":"1192_CR22","unstructured":"Gross Domestic Product by State and Personal Income by State, 1st Quarter 2025. US Bureau of Economic Analysis. 2025. https:\/\/www.bea.gov\/news\/2025\/gross-domestic-product-state-and-personal-income-state-1st-quarter-2025."},{"key":"1192_CR23","first-page":"103","volume":"10","author":"L McVicker","year":"2024","unstructured":"McVicker L, Labeit AM, Coupland CAC, Hicks B, Hughes C, McMenamin \u00da, et al. Vaginal estrogen therapy use and survival in females with breast cancer. Journal of the American Medical Association Oncology. 2024;10:103\u20138.","journal-title":"Journal of the American Medical Association Oncology"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41443-025-01192-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-025-01192-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-025-01192-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:06:34Z","timestamp":1761908794000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41443-025-01192-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":23,"alternative-id":["1192"],"URL":"https:\/\/doi.org\/10.1038\/s41443-025-01192-6","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"2 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"YAF: Coloplast: Advisory board, speaker; Endo: Advisory board; Haledon: Advisory board; Halozyme: Advisory board, speaker; Masimo: Intellectual property; Software: Advisory board; Sprout: Consultant; Vertica: Research investigator; Xiaoli: Advisory board. The remaining Authors have no conflicts of interest to disclose. Views expressed herein are those of the author and do not necessarily reflect the official policy or position of the Defense Health Agency, Brooke Army Medical Center, Wilford Hall Ambulatory Surgical Center, and the Department of Defense, nor any agency under the U.S. Government.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study did not involve human participants, identifiable personal data, or clinical interventions, and therefore did not require ethical approval. All data analyzed were publicly available through Google Trends and published literature databases.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}